We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sanofi pasteur and GlaxoSmithKline (GSK) have received multimillion dollar contracts from the HHS to supply treatments that would be used in the event of an influenza pandemic.
The HHS has awarded multimillion dollar contracts to sanofi pasteur and GlaxoSmithKline (GSK) for treatments that would be used in the event of an influenza pandemic.
The NIH has issued its final ethics policy that maintains a strict ban on employee consultations with pharmaceutical and biotechnology firms while allowing NIH scientists to engage in teaching and other compensated activities.
Dutch firm Bavarian Nordic has accused Acambis of patent infringement, charging that its British rival used stolen trade secrets to develop a competing smallpox vaccine.
The NIH needs to do a better job of monitoring outside work by its scientists to prevent questionable arrangements such as the secret consulting between NIH scientists and drug companies uncovered last year, says a report by HHS Inspector General Daniel Levinson.
The Centers for Medicare & Medicaid Services’ (CMS) proposed competitive acquisition program (CAP) for Medicare Part B drugs is flawed and could leave physicians and vendors open to substantial risks, according to cancer services network US Oncology, which is pressuring the agency to revise the program.
An internal NIH investigation has revealed dozens of agency scientists performed work for drug companies in violation of federal ethics requirements — findings that indicate concerns about improprieties at the agency might have been worse than originally believed.
The Centers for Medicare and Medicaid Services (CMS) is proposing to reimburse hospitals for outpatient drugs used under Medicare in 2006 at 108 percent of the manufacturer’s average sales price (ASP), according to the agency’s proposed Outpatient Prospective Payment System (OPPS) rule.
Key Republican lawmakers overseeing federal prescription drug programs are calling on the Centers for Medicare & Medicaid Services (CMS) to lower its payment levels for outpatient drugs dispensed by hospitals under Medicare.